Fireside Ventures leads funding round of Rs 50 crore in Amaha

Published On 2024-02-11 06:30 GMT   |   Update On 2024-02-11 06:30 GMT

Mumbai: Amaha has announced securing a substantial investment of over INR 50 crore as an extended series A round. This round of funding was led by Fireside Ventures investing INR 36.4 crore as well as additional investment of INR 15+ crore by other strategic investors.

"Over time, Amaha has successfully raised one of the largest investments in mental health in India," the Company stated. 

The Amaha mental health ecosystem provides treatment and care for a range of mental health conditions like anxiety, depression, bipolar disorder, ADHD, OCD, schizophrenia, and addictions. The organisation was founded by psychiatrist and healthcare entrepreneur Dr Amit Malik and joined by social entrepreneur Neha Kirpal as co-founder, to address the mental health treatment gap prevalent in India.

Advertisement

Dr. Amit Malik, Founder and CEO of Amaha, expressing his eagerness about the recent funding, stated, “The INR 50+ Crore infusion helps consolidate Amaha’s position as the leading mental healthcare provider in India and accelerates the company’s strategic expansion plans, as it continues to address the dynamic mental health challenges faced by individuals, families and organisations across the country. The partnership with Fireside Ventures creates exciting possibilities for cross-sectoral collaborations, propelling Amaha’s efforts to mainstream mental health access to all those in need.”

Ankur Khaitan, Principal, Fireside Ventures said, “At Fireside, our outlook is to look for companies building for well-being and in that context, the space of addressing mental health issues is a large unmet need in India. Amaha with their deep clinical expertise and unique business model across digital and offline clinics will be able to solve for awareness and access to a wider audience.”

Amaha acquired & partnered with India’s foremost Child and Adolescent mental health organisation Children First two years ago. 

Read also: Strides Pharma shares sold by 2 entities for Rs 81 crore

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News